The link between cardiac surgery and kidney failure: trayslol
February 7, 2007: Cardiac surgery patients who have experienced kidney failure following their surgery may have been given the drug called Trayslol - it's estimated the drug may have been given to nearly 1 million patients.
Background:
Trayslol, also known as aprotinin and manufactured by Bayer, is a medicine given before heart surgery to reduce bleeding and the need for blood transfusions. Since Trayslol is given during heart procedures, most patients don't even know they were given the drug. In January of 2006, it was reported that Trayslol administration may increase the risk of renal toxicity. Other reports link Trayslol with increased risk of kidney failure, cardiovascular events (myocardial infarction or heart failure), cerebrovascular events such as a stroke, encephalopathy or coma. Based on these findings the FDA issued an alert in response to the articles that it is working with Bayer and reviewing pre-marketing and post-marketing reports, warning physicians to monitor patients for problems. Bayer recently revealed to the FDA the results of a large study suggesting that Trasylol increases the risks of severe side effects.
Where can I find additional information?
What you can do:
If you think you may have been given the Trayslol and are experiencing any serious side effects you are urged to seek medical attention. If you have experienced kidney failure and are now on dialysis, it may also be important to contact an attorney who can help you protect your potential legal claim. If you would like more information, or would just like to talk with a lawyer experienced in this litigation, please call attorney Stacy Hauer at 1.800.755.0098 for a free consultation or click here to fill out an online free case review.
|
